sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Cell Therapy Market Size & Forecast

Download Free Sample View Report Summary
Historic: 2022-2024 Base Year: 2025 Forecast: 2026–2033
US$ 8.10 Billion
Market Size 2025 · Base Year
US$ 43.96 Billion
Projected Market Size by 2033
23.5%
CAGR · 2026–2033
Download Free Sample View Report Summary
sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608
SHARE
BMIPUB00036469 56+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa
12
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)
10 +
Major Players
Major companies profiled including Novartis AG, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Autolus Therapeutics plc
350
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • Increasing Cancer Treatment Demand

  • Rising Regenerative Medicine Adoption

  • Growing Stem Cell Research

Where Growth Opportunities Exist

Key Opportunities

  • Expanding Clinical Trial Pipeline

  • Growing Rare Disease Treatments

  • Increasing Healthcare Investments Globally

What Could Slow It Down

Market Restraints

  • High Therapy Development Costs

  • Complex Regulatory Approval Processes

  • Limited Manufacturing Scalability

Market Segmentation

Coverage by Segment

Therapy Type

CAR-T Cell Therapy
TCR-T Cell Therapy
Natural Killer Cells

Product

Kymriah
Yescarta
Tecartus

Indication

Oncology
Others

End User

Hospitals & Clinics
Specialty Clinics
Others
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

Novartis AG
Gilead Sciences, Inc.
Bristol-Myers Squibb Company
Johnson & Johnson
Autolus Therapeutics plc
Bluebird Bio, Inc.
Takeda Pharmaceutical Company Limited
Vertex Pharmaceuticals Incorporated
Mesoblast Limited
Allogene Therapeutics, Inc.
What's Inside

Report Scope & Deliverables

Market Size 2025 US$ 8.10 Billion
Market Size 2033 US$ 43.96 Billion
CAGR 2026–2033 23.5%
Segments By Therapy Type (CAR-T Cell Therapy, TCR-T Cell Therapy, Natural Killer Cells)  |  By Product (Kymriah, Yescarta, Tecartus)  |  By Indication (Oncology, Others)
Geographies North America (US, Canada, Mexico)  ·  Europe (Germany, Italy, France, U.K., Spain, Belgium, Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Switzerland, Austria, Greece, Portugal, Russia, Poland, Romania, Czech Republic, Ukraine, Slovakia, Bulgaria)  ·  Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh)  ·  South and Central America (Brazil, Argentina, Chile, Colombia, Peru)  ·  Middle East and Africa (Saudi Arabia, United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIPUB00036469
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 350 pages of in-depth Cell Therapy Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.

Request Customization Download Free Sample